Literature DB >> 13451889

Sequelae of western equine and other arthropod-borne encephalitides.

H HERZON, J T SHELTON, H B BRUYN.   

Abstract

Entities:  

Keywords:  ENCEPHALOMYELITIS, EQUINE/pathology

Mesh：

Year:  1957        PMID： 13451889     DOI： 10.1212/wnl.7.8.535

Source DB:  PubMed          Journal:  Neurology        ISSN： 0028-3878            Impact factor:   9.910


× No keyword cloud information.
  8 in total

1.  Arthropod-borne encephalitis in the United States, 1957.

Authors:  J A BRODY; W A MURRAY
Journal:  Public Health Rep       Date:  1959-05       Impact factor: 2.792

2.  Immunopathogenesis of alphaviruses.

Authors:  Victoria K Baxter; Mark T Heise
Journal:  Adv Virus Res       Date:  2020-07-08       Impact factor: 9.937

3.  Follow-up studies of st. Louis encephalitis in Florida: sensorimotor findings.

Authors:  G J Azar; G L Chappell; A H Lawton; J O Bond
Journal:  Am J Public Health Nations Health       Date:  1966-07

4.  St. Louis encephalitis sequelae and accidents.

Authors:  G J Azar; A H Lawton
Journal:  Public Health Rep       Date:  1966-02       Impact factor: 2.792

5.  Western encephalitis: report of eight fatal cases. Saskatchewan epidemic, 1965.

Authors:  B Rozdilsky; H E Robertson; J Chorney
Journal:  Can Med Assoc J       Date:  1968-01-13       Impact factor: 8.262

6.  Mouse Model of Neurological Complications Resulting from Encephalitic Alphavirus Infection.

Authors:  Shannon E Ronca; Jeanon Smith; Takaaki Koma; Magda M Miller; Nadezhda Yun; Kelly T Dineley; Slobodan Paessler
Journal:  Front Microbiol       Date:  2017-02-07       Impact factor: 5.640

Review 7.  Epidemic Alphaviruses: Ecology, Emergence and Outbreaks.

Authors:  Sasha R Azar; Rafael K Campos; Nicholas A Bergren; Vidyleison N Camargos; Shannan L Rossi
Journal:  Microorganisms       Date:  2020-08-01

Review 8.  Neurological Sequelae Resulting from Encephalitic Alphavirus Infection.

Authors:  Shannon E Ronca; Kelly T Dineley; Slobodan Paessler
Journal:  Front Microbiol       Date:  2016-06-20       Impact factor: 5.640
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.